Haloperidol and Respiratory Depression

Critical Drug Interactions

• The European Society for Medical Oncology (ESMO) guidelines warn about combining olanzapine with benzodiazepines due to risk of oversedation and respiratory depression, and this caution extends to all antipsychotic-benzodiazepine combinations, including haloperidol 1
• Opioids and benzodiazepines are the primary psychotropic drug classes causing clinically significant respiratory depression, with synergistic effects when combined 2
• The combination of any CNS depressant with haloperidol requires increased vigilance, as patients receiving combined therapy require increased intensity and duration of monitoring, as recommended by the American Society of Anesthesiologists (ASA) 3, 2

Clinical Management Recommendations

• The ESMO guidelines recommend using lower starting doses (0.25-0.5 mg) of haloperidol in older, frail patients, or those with COPD 1
• The ESMO guidelines also recommend avoiding concurrent benzodiazepines whenever possible; if both are required, use the lowest effective doses and increase monitoring 1, 2
• The National Comprehensive Cancer Network (NCCN) recommends monitoring for progressive sedation, as sedation often precedes respiratory depression 4
• The NCCN also recommends having naloxone available if opioids are co-administered, though it does not reverse haloperidol effects 4

Common Pitfalls to Avoid

• The ASA recommends enhanced monitoring when adding any parenteral opioid, sedative, or hypnotic to haloperidol, as this increases respiratory depression risk 3, 2